Joint Action

We recently published the results from a large randomised controlled trial investigating the effects of platelet-rich plasma for knee osteoarthritis. On this episode, we are joined by Prof Kim Bennell to discuss the results of the study.Prof Kim Bennell is a research physiotherapist and her current positions include Redmond Barry Distinguished Professor and Director of the Centre for Health, Exercise and Sports Medicine (CHESM), in Physiotherapy at the School of Health Sciences, University of Melbourne, NHMRC Investigator Fellow (L2) and Director of the NHMRC Centre of Research Excellence in Translational Research in Musculoskeletal Pain. She leads a multidisciplinary team including people from physiotherapy, medicine, exercise science, podiatry and psychology. Kim’s research focuses on conservative non-drug management of musculoskeletal conditions particularly osteoarthritis with an emphasis on the role of exercise in both prevention and management.RESOURCESResearch paper: Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis - The RESTORE Randomized Clinical TrialEditorial: Platelet-Rich Plasma for Osteoarthritis and Achilles TendinitisCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastThis is our last episode of the year, if you haven't already, please subscribe so you don't miss out on new episodes! We would also be very grateful if you could leave us a review :) Hosted on Acast. See acast.com/privacy for more information.

Living with a musculoskeletal condition such as arthritis is not easy. The associated symptoms such as pain and stiffness make everyday activities that once seemed easy, challenging. It is important that those living with arthritis are educated and empowered to make decisions about the management about their condition and healthcare. However, this is not always the case with studies showing that only one-third of patients seeking care for their osteoarthritis are satisfied with their treatment. Health care providers and their patients need to ensure that management of the condition is collaborative and that patients have the appropriate tools and skills to successfully manage their condition. On this episode of Joint Action, we are joined by Dawn Richards to discuss how patients can be empowered to take control of their condition. Dawn completed a PhD (Analytical Chemistry) from the University of Alberta and has worked in a variety of roles during the past 20 years, however her diagnosis with rheumatoid arthritis almost 15 years ago instigated a journey to intertwine her passion for science with making the most of her diagnosis. Dawn was more recently diagnosed (a year ago) with knee OA. As a patient advocate and volunteer, Dawn is Vice President of the Canadian Arthritis Patient Alliance and a member of The BMJ’s Patient Panel. She served as an IMHA Research Ambassador from 2014 - 2019 and was the first Patient Advisor of the Canadian Medical Association’s Wait Time Alliance. Dawn advocates for arthritis awareness, access to treatment, the importance of research and the inclusion of patients both in decision-making and as research collaborators.RESOURCESGLA:D Australia GLA:D CanadaTREK education: manage my knee cap painThe BMJ: Motivational InterviewingMotivational Interviewing Network of TrainersAustralian Family Practice: Motivational interviewing techniques - facilitating behaviour change in the general practice settingCONNECT WITH DAWNTwitter: @TO_dprCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

The number of surgical procedures for musculoskeletal diseases such as osteoarthritis has increased exponentially over the past years, some of which are unnecessary and leave patients no better off than they were before. Knee replacement surgery can be a wonderful and cost-effective treatment for end-stage osteoarthritis but only when less invasive treatments have failed. There are many factors driving the alarming rates of increased surgery ranging from system-level factors such as inadequate reimbursement for physiotherapy treatment to personal-level factors such as individual beliefs and education of patients and their health care providers. Frequently referrals are made to surgeons as primary care doctors feel there is nothing more they can do. If you are referred it is important to be prepared for what that consultation will involve and to consider whether you truly want/ need surgery.On this episode of Joint Action, we are joined by Dr Howard Luks to discuss this topic.Dr. Howard Luks is a Board-Certified Orthopaedic Surgeon and Sports Medicine specialist. Howard graduated from New York Medical College and completed his Orthopaedic Surgery residency in 1996 and a fellowship in Sports Medicine at the Hospital for Joint Diseases in NYC in 1997. His focus is on injuries that involve the shoulder, knee, and elbow. He is the Chief of Sports Medicine and Arthroscopy at New York Medical College and Advanced Physician Services. CONNECT WITH HOWARDTwitter: @hjluksWebsite: https://www.howardluksmd.com/Podcast: https://www.howardluksmd.com/podcast/the-paul-and-howard-show/CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

Although research has consistently demonstrated what is required to manage osteoarthritis appropriately, this is not the reality experienced by most. The current treatment for osteoarthritis is often reactive, using treatments which are not beneficial and often harmful and expensive to patients. The limitations in the current health system call for new models of osteoarthritis care to support ongoing symptom relief and self-management that are proactive and preventative. Re-engineering our health care system may be facilitated by considering how health professionals are paid. At present this is based on activity, with little heed paid to quality or outcome. On this episode of Joint Action, we are joined by Kevin Cheng to discuss health system redesign and value based primary care in osteoarthritis.Dr Kevin Cheng is an Australian-trained GP specialising in chronic disease management and integrated care. He trained at the University of WA, has a fellowship with the Royal Australian College of General Practitioners and a MBA from INSEAD in France. He has interests in lifestyle medicine, health system reform and data analytics in healthcare. Kevin has over 20 years experience as a doctor working in urban and rural areas in Australia, plus sabbaticals in Kenya, Hong Kong, and England as a clinician and in health policy. He has developed innovative programs for Governments, health insurers, hospitals, and pharmaceutical companies. He is an industry expert in models of health care, population health management and chronic disease care. Kevin also worked for strategy consulting firms McKinsey & Company and Boston Consulting Group, leading business transformations in public sector and private industries such as retail banking, manufacturing, mining, education, and technology. He is the founder of Osana, a general practice corporate.CONNECT WITH KEVINWebsite: https://osana.care/CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

The COVID-19 pandemic has forced us to shift how we deliver care to those living with osteoarthritis. There has been an increasing number of online resources including websites, decision aids, remotely delivered programs and podcasts such as Joint Action which have become increasingly popular in the past year. With the numerous resources available, how do we know which programs are suitable and evidence-based? The OARSI Joint Effort Initiative is a collaboration between international clinicians and researchers with an interest in the implementation of OA management programs. Their aim is to improve overall care with a focus on core interventions such as education, exercise and weight management.  On this episode of Joint Action, we are joined by Dr Jillian Eyles and Dr Jocelyn Bowden to discuss the OARSI Joint Effort Initiative and online resources for osteoarthritis. RESOURCESLEARN MORE ABOUT THE OARSI JOINT EFFORT INITIATIVEOnline Osteoarthritis Management Programs repository Joint Action website OA consumer and consumer advocacy organisationsArthritis AustraliaVersus Arthritis (UK)Arthritis Society (Canada)Osteoarthritis Foundation International (Spain)Arthritis Foundation (USA)OA Action Alliance (USA) Other organisationsNPS MedicineWise: Knee and hip osteoarthritis. (Australia)Centers for Disease Control and Prevention (USA): chronic disease Self-management programJoint Implementation of Osteoarthritis Guidelines Across Western-Europe (JIGSAW-E)Australian Heart FoundationCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

Biological markers or commonly referred to as biomarkers are biological measures or medical signs which can be measured accurately and reproducibly in patients. Examples of biomarkers can be anything from pulse and blood pressure to more complex blood tests and other tissues. There are different types of biomarkers including systemic and molecular biomarkers and the investigation of these provide potential targets for developing osteoarthritis disease-modifying drugs.On this episode of Joint Action, we are joined by Virginia Kraus to discuss the role of biomarkers in osteoarthritis and in particularly their role in drug development.Virginia Kraus is a Professor of Medicine at the Duke University School of Medicine. She is a practicing Rheumatologist with over 20 years experience in musculoskeletal research focusing on osteoarthritis. She is an adjunct Professor of Pathology and an adjunct Associate Professor of Surgery. Her career has focused on elucidating osteoarthritis pathogenesis and translational research into the discovery and validation of biomarkers for early osteoarthritis detection, prediction of progression, and monitoring of disease status.Listen to Virginia and The Women's Voices Chorus here.CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

Sleep disturbances are common in those with osteoarthritis. Research has postulated that poor night time sleep is associated with increased pain the following day and that sleep disturbances are associated with increased risk for developing or worsening pain in the long-term. The interactions between pain and sleep are complex.  On this episode of Joint Action, we are joined by Peter Cistulli to discuss the relationship between sleep and pain and how we can improve sleep.  Professor Peter Cistulli holds the ResMed Chair in Sleep Medicine at the University of Sydney, where he leads the Sleep Research Theme within the multidisciplinary Charles Perkins Centre. He heads the Discipline of Sleep Medicine within the Faculty of Medicine and Health. He is also Director of the Centre for Sleep Health & Research in the Department of Respiratory and Sleep Medicine at Royal North Shore Hospital, Sydney. He is an active clinician researcher with 28 years experience in in the fields of respiratory and sleep medicine. His thematic research has focussed on the pathophysiology of Sleep-disordered Breathing, and novel approaches to therapy. RESOURCESThe Sleep Health FoundationSleep Quality and Fatigue Are Associated with Pain Exacerbations of Hip Osteoarthritis CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

The prevalence of osteoarthritis continues to grow with the increasing rates of obesity. Obesity is a major risk factor for the progression of osteoarthritis and those who are obese are at an increased risk for requiring a total knee replacement. By preventing weight-related osteoarthritis as well as helping to manage people’s weight, we may be able to reduce the burden of OA. The effects of weight loss on knee osteoarthritis pain have been well established, however, is difficult to achieve for most people. On this episode of Joint Action, we are joined by Dr Jonathan Samuels to discuss the role of bariatric weight loss and how it may delay or eliminate the need for total knee replacement in some.Dr Jonathan Samuels is a rheumatologist at NYU Langone Health, located in Manhattan, New York. He is an Associate Professor in the Department of Medicine at NYU Grossman School of Medicine. Dr Samuels’ focus is on osteoarthritis of the hip and knee and he strives to contribute to significant breakthroughs in this area by working in collaboration with orthopaedic and bariatric specialists.RESOURCESPredictors of the effect of bariatric surgery on knee osteoarthritis painSurgical weight-loss to improve functional status trajectories following total knee arthroplasty: SWIFT trial: Rationale, design, and methodsCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

Managing osteoarthritis pain remains a challenge for patients and clinicians. Non-steroidal anti-inflammatory drugs are often used despite the potential risk associated with long-term use. In recent years, new advances have led to the exploration of central acting medications such as duloxetine for osteoarthritis pain. Despite this, those with OA continue to suffer from inadequate pain relief. By better understanding the pathways which influence pain, we may be able to better treat OA pain by identifying potential therapeutic targets. On this episode of Joint Action, we are joined by Anne-Marie Malfait to discuss where osteoarthritis pain comes from. Anne Marie’s research focuses on pain osteoarthritis. She is the Professor of Internal Medicine and The George W. Stuppy, MD, Chair of Arthritis at Rush University in Chicago IL. Anne-Marie received her MD degree in 1989 and her PhD in 1994, both from Ghent University in Belgium. Her early research training focused on cartilage metabolism in osteoarthritis. Her postdoctoral training at the Kennedy Institute of Rheumatology in London focused on the role of cytokines in inflammatory arthritis. In 2001, she joined the pharmaceutical industry, joining a team for the development of disease-modifying osteoarthritis drugs (DMOADs). Since 2009, Anne Marie has been at Rush University, and established a research group studying pain in osteoarthritis, using animal models. Her group studies the relationship between joint damage and the neurobiological processes that underlie OA pain, with the long-term goal to develop more efficacious and safer analgesics and DMOADs. CONNECT WITH ANNE-MARIETwitter: @AM_MalfWebsite: http://www.annemariemalfait.com/CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.

Despite the numerous guidelines supporting exercise and weight loss/management for osteoarthritis, they are challenging to implement in day-to-day life. Key actions for management are often not reaching health care providers and patients do not always receive high-value care. One of the biggest barriers to behaviour change is getting people to start and adhere to a lifestyle intervention. On a systems level, there are major challenges with access to care and communication regarding optimal care. On this episode of Joint Action, in an era being affected by COVID, Julie Leask joins us to discuss how we can improve behaviour change in OA from our learnings from current vaccination strategies. Julie is professor at the University of Sydney’s Susan Wakil School of Nursing and Midwifery. Her research over 23 years has focused on the social and behavioural aspects of immunisation – what people think and do about it, programs and policies. She has a Master of Public Health and nursing and midwifery qualifications. Julie is visiting fellow at the National Centre for Immunisation Research and Surveillance where she previously worked for 12 years and set up the social science unit. She currently chairs the WHO Behavioural and Social Drivers of Vaccination working group. In 2019, Julie was the overall winner of the Australian Financial Review 100 Women of Influence award.RESOURCESSharing Knowledge About Immunisation for Providers: Talking About ImmunisationSharing Knowledge About Immunisation: Talking About ImmunisationThe Osteoarthritis Action Alliance: Communicating with PatientsThe BMJ: Motivational InterviewingMotivational Interviewing Network of TrainersAustralian Family Practice: Motivational interviewing techniques - facilitating behaviour change in the general practice settingCONNECT WITH JULIETwitter: @JulieLeaskBlog: https://julieleask.wordpress.com/CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! Hosted on Acast. See acast.com/privacy for more information.